These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16750374)

  • 1. CoMFA and CoMSIA investigations of dopamine D3 receptor ligands leading to the prediction, synthesis, and evaluation of rigidized FAUC 365 analogues.
    Salama I; Schlotter K; Utz W; Hübner H; Gmeiner P; Boeckler F
    Bioorg Med Chem; 2006 Sep; 14(17):5898-912. PubMed ID: 16750374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
    Salama I; Hocke C; Utz W; Prante O; Boeckler F; Hübner H; Kuwert T; Gmeiner P
    J Med Chem; 2007 Feb; 50(3):489-500. PubMed ID: 17266201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and radioiodination of selective ligands for the dopamine D3 receptor subtype.
    Hocke C; Prante O; Löber S; Hübner H; Gmeiner P; Kuwert T
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3963-6. PubMed ID: 15225707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further SAR study on 11-O-substituted aporphine analogues: identification of highly potent dopamine D3 receptor ligands.
    Ye N; Wu Q; Zhu L; Zheng L; Gao B; Zhen X; Zhang A
    Bioorg Med Chem; 2011 Mar; 19(6):1999-2008. PubMed ID: 21334902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of tetrahydrothiophenes and tetrahydrofurans and studies of their derivatives as melanocortin-4 receptor ligands.
    Tran JA; Chen CW; Tucci FC; Jiang W; Fleck BA; Chen C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1124-30. PubMed ID: 18082401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands.
    Insua I; Alvarado M; Masaguer CF; Iglesias A; Brea J; Loza MI; Carro L
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5586-91. PubMed ID: 24012118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor.
    Hocke C; Prante O; Salama I; Hübner H; Löber S; Kuwert T; Gmeiner P
    ChemMedChem; 2008 May; 3(5):788-93. PubMed ID: 18306190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.
    Jean M; Renault J; Levoin N; Danvy D; Calmels T; Berrebi-Bertrand I; Robert P; Schwartz JC; Lecomte JM; Uriac P; Capet M
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5376-9. PubMed ID: 20708933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.
    Boeckler F; Ohnmacht U; Lehmann T; Utz W; Hübner H; Gmeiner P
    J Med Chem; 2005 Apr; 48(7):2493-508. PubMed ID: 15801839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides.
    Heidler P; Zohrabi-Kalantari V; Calmels T; Capet M; Berrebi-Bertrand I; Schwartz JC; Stark H; Link A
    Bioorg Med Chem; 2005 Mar; 13(6):2009-14. PubMed ID: 15727854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.
    Hackling A; Ghosh R; Perachon S; Mann A; Höltje HD; Wermuth CG; Schwartz JC; Sippl W; Sokoloff P; Stark H
    J Med Chem; 2003 Aug; 46(18):3883-99. PubMed ID: 12930150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
    Ji M; Chen J; Ding K; Wu X; Varady J; Levant B; Wang S
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1701-5. PubMed ID: 15745825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Leopoldo M; Lacivita E; Colabufo NA; Contino M; Berardi F; Perrone R
    J Med Chem; 2005 Dec; 48(25):7919-22. PubMed ID: 16335915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalent molecular probes for dopamine D2-like receptors.
    Huber D; Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem; 2012 Jan; 20(1):455-66. PubMed ID: 22100258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.
    Mach UR; Hackling AE; Perachon S; Ferry S; Wermuth CG; Schwartz JC; Sokoloff P; Stark H
    Chembiochem; 2004 Apr; 5(4):508-18. PubMed ID: 15185375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
    Elsner J; Boeckler F; Heinemann FW; Hübner H; Gmeiner P
    J Med Chem; 2005 Sep; 48(18):5771-9. PubMed ID: 16134944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
    Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
    Möller D; Salama I; Kling RC; Hübner H; Gmeiner P
    Bioorg Med Chem; 2015 Sep; 23(18):6195-209. PubMed ID: 26299826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.